OIL

OPTISCAN FPO [OIL]
Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinical and translational research. The company also provides InSpecta, a novel digital microscopic imaging device for veterinary medicine. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.
Technology · ASX Small Cap
$0.1550 +0.0%

Updated 21 Jul 2026 · Signals refresh every scan

Get alerts when OIL triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track OIL — Free

Active Signals

Bullish Signals

  • Trading above both moving averages — the trend is your friend here
  • Beating the Small Ords index — relative strength of 1.39, so it's outpacing the pack
  • Trading above the 200-day average — the long-term trend is on your side
  • Strong cash runway (11 quarters)
  • Very high P/S ratio (66.4x)
  • Revenue in sharp decline (-46%)
  • Near 52-week high (94% of range)
  • CANSLIM N: Near 52-week high (breakout territory)
  • CANSLIM S: Tight float (37%)
  • CANSLIM I: Institutional ownership (15%)
  • Sentiment is mixed — no strong consensus either way
  • Positive long-term momentum — up 45% over the past year
  • The bigger volume days are the up days — volume-weighted momentum is positive (2.44%/day)
  • RBA hiking (-3pts)

Risk Signals

  • Stochastic is stretched into overbought — could need a breather
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Revenue declining at -46% — the top line is shrinking
Ask Scout AI about OIL
"What's driving OIL today?" "How does OIL compare to peers?" "Key risks for OIL?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Optiscan Launches InSpecta Device for Veterinary Medicine
NONE Halfway Mark Reached in Optiscan Breast Cancer Study
NONE Second Anniversary of Optiscan and Mayo Clinic Agreement

Recent ASX Announcements

2026-07-06 Optiscan Launches InSpecta Device for Veterinary Medicine PRICE SENSITIVE
2026-06-03 Halfway Mark Reached in Optiscan Breast Cancer Study PRICE SENSITIVE
2026-06-01 Second Anniversary of Optiscan and Mayo Clinic Agreement PRICE SENSITIVE
2026-05-25 Change of Director's Interest Notice

Key Metrics

$161.8M
Market Cap
344K
Avg Volume
0.7x
Vol Ratio
$0.08 — $0.16
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-43.6%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / CatalystspassNear 52w High
SSupply & DemandpassFloat: 37%
LLeader vs LaggardpassRS: 12
IInstitutional SponsorshippassInst: 15%
MMarket DirectionneutralNeutral

Sector: Technology

90 tickers in this sector

View all Technology signals →Browse all ASX tickers A–Z →
Related Tickers
AMS +18.8%GTI -14.8%ATV +12.5%TAL +11.7%ROC -10.0%
Compare:OIL vs AMSOIL vs GTIOIL vs ATV
Scout Pro — Deeper Analysis for OIL
Try Pro free for 30 days
Share this analysis

Track OIL and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required